AGP Executive Report
Last update: 32 minutes agoFood Safety: India’s FSSAI has challenged Nestlé, Zydus Wellness and Abbott over infant-formula and children’s product claims, seeking support for statements about immunity, digestion and growth. It also flagged an influencer’s promotion of infant formula. Hepatitis B: GSK and Ionis’ six-month add-on treatment bepirovirsen won U.S. approval for a subset of adults with chronic hepatitis B; Japan has also approved the drug. Health Services: China plans 1,000 county-level chronic-pain centers, while India is preparing new blood-cancer treatments for trials. Women’s Health: Indian sugarcane workers face pressure to undergo hysterectomies to avoid lost wages; a survey in Beed found nearly 14,000 of 82,000 migrant women had undergone the surgery. Climate & Health: The UN warns El Niño could drive record Pacific warming, bringing greater risks of floods and droughts across the region.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
